For the Patient: LUOTPAC

Similar documents
For the Patient: LUSCPE

For the Patient: SAAJAP

For the Patient: LUPUPE

For the Patient: LUAVNP

For the Patient: LUPUPE (Carboplatin Option)

For the Patient: Epirubicin Other names: PHARMORUBICIN

For the Patient: LUSCCAV

For the Patient: LUSCTOP

For the Patient: GIA Other Names: Palliative chemotherapy for cancer of the liver (hepatoma) using Doxorubicin

For the Patient: LUAJPC

For the Patient: LUAVPP

For the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine

For the Patient: LUAVPP (Carboplatin Option)

For the Patient: LUAVPG

For the Patient: GIAVPG Other Names: First-line palliative chemotherapy for advanced gallbladder and bile duct cancer using Gemcitabine and Cisplatin

For the Patient: ULUAVPMTN

ABOUT THIS MEDICATION

For the Patient: LUAVPG (Carboplatin Option)

What are these drugs used for? Paclitaxel and carboplatin are intravenous anticancer medications used for many types of cancer.

For the Patient: Amsacrine Other names: AMSA PD

For the Patient: Paclitaxel Other names: TAXOL

For the Patient: Mitoxantrone Other names:

For the Patient: LUAVDC

For the Patient: Methotrexate Other names: MTX

For the Patient: Doxorubicin pegylated liposomal Other names: CAELYX, DOXIL, PLD

For the Patient: GIPE Palliative therapy of neuroendocrine tumours using Cisplatin and Etoposide

For the Patient: HNAVFUP Treatment for Advanced Squamous Cell Cancer of the Head and Neck using Fluorouracil and Platinum

For the Patient: GOOVCATM

For the Patient: LULAPERT

For the Patient: GOOVCATR

For the Patient: LUAVPEM

For the Patient: GOOVDDCAT

For the Patient: GDP-R Other names: LYGDPR

For the Patient: Bendamustine Other names: TREANDA

For the Patient: Eribulin Other names: HALAVEN

For the Patient: Fludarabine injection Other names: FLUDARA

For the Patient: GUBEP

For the Patient: Cyclosporine injection Other names: SANDIMMUNE I.V.

ABOUT THIS MEDICATION What is this drug used for? Gemcitabine is an intravenous anticancer medication used for some types of cancer.

For the Patient: Trastuzumab emtansine Other names: KADCYLA

For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide

For the Patient: Ponatinib Other names: ICLUSIG

For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.

ABOUT THIS MEDICATION

ABOUT THIS MEDICATION What are these drugs used for? Docetaxel is an anticancer drug used to treat cancers in the area of the neck and throat.

For the Patient: ACTW Other names: BRAJACTW

U = Undesignated GI = GastroIntestinal AJ = Adjuvant RALOX = Raltitrexed, Oxaliplatin

For the Patient: GOCXCATB

ABOUT THIS MEDICATION

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth.

For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide

For the Patient: GIENACTRT Treatment of esophageal and gastroesophageal cancer, prior to surgery, using Carboplatin, Paclitaxel and Radiation Therapy.

For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin)

For the Patient: Sunitinib Other names: SUTENT

For the Patient: Rituximab injection Other names: RITUXAN

ABOUT THIS MEDICATION

ABOUT THIS MEDICATION

For the Patient: Cobimetinib tablets Other names: COTELLIC

For the Patient: Everolimus tablets Other names: AFINITOR

Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.

For the Patient: Olaparib tablets Other names: LYNPARZA

Treatment Plan: Drugs:

GI = GastroIntestinal FOLFIRI = Folinic Acid, Fluorouracil, Irinotecan

For the Patient: Lenvatinib Other names: LENVIMA

For the Patient: GIPAVCAP Other Names: Second line treatment of metastatic or unresectable pancreatic adenocarcinoma using Capecitabine

This therapy is being given to treat your cancer of the anal canal with the intention of cure.

For the Patient: DC. D Docetaxel (TAXOTERE ) C Cyclophosphamide

For the Patient: UGINETEV Other Names: Treatment of advanced neuroendocrine tumours of gastrointestinal origin (Non-Functional) using Everolimus

For the Patient: Lenalidomide Other names: REVLIMID

For the Patient: Alemtuzumab SC injection Other names: MABCAMPATH, CAMPATH

For the Patient: USMAVTRA Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Trametinib

For the Patient: ACD

For the Patient: GIPAJGCAP Other Names: Adjuvant chemotherapy for pancreatic adenocarcinoma using Gemcitabine and Capecitabine

For the Patient: GIAVTZCAP Other Names: Palliative therapy of metastatic neuroendocrine cancer of the pancreas, using Temozolomide and Capecitabine

What are these drugs used for? Irinotecan, fluorouracil (5FU), leucovorin and bevacizumab are drugs given to treat colon or rectal cancer.

= GastroIntestinal Gastric (stomach) = Advanced = Fluorouracil, Folinic Acid, OXaliplatin ABOUT THIS MEDICATION

For the Patient: LYEPOCHR Other Names: DA-EPOCHR

ABOUT THIS MEDICATION

What are these drugs used for? Irinotecan, fluorouracil (5FU), leucovorin, and panitumumab are drugs given to treat metastatic colorectal cancer.

GI = GastroIntestinal FIRINOX = Fluorouracil, Irinotecan, Infusional fluorouracil, Oxaliplatin

For the Patient: GIAJCAPOX Other Names: Adjuvant combination chemotherapy for Stage III and IIB colon cancer using capecitabine and oxaliplatin.

For the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab

ABOUT THIS MEDICATION

For the Patient: GICART Other Names: Curative therapy for cancer of the anal canal using combined Mitomycin, Capecitabine and Radiation Therapy

For the Patient: GUPDOCADT

For the Patient: CAP. Capecitabine. Uses:

You are being asked to take octreotide as a treatment to manage the symptoms of your cancer.

For the Patient: GIRCRT Adjuvant therapy for high risk cancer of the rectum with combined Capecitabine and Radiation Therapy

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

What are these drugs used for? Oxaliplatin, bevacizumab and capecitabine are drugs given to treat cancer of the colon or rectum.

For the Patient: Afatinib Other names: GIOTRIF, GILOTRIF

For the Patient: Vemurafenib Other names: ZELBORAF

For the Patient: UMYLDREL

For the Patient: USMAVFIPI

Docetaxel (Taxotere )

ABOUT THIS MEDICATION

INTENDED BENEFITS You are being asked to take these drugs as a treatment to reduce the risk of recurrence of cancer of the stomach or esophagus.

For the Patient: ULUAVPMB

Transcription:

For the Patient: LUOTPAC Other Names: Treatment of Thymoma with Cisplatin, Doxorubicin and Cyclophosphamide LU = LUng OT = Other Thoracic: Thymoma/Thymic Carcinoma P = CisPlatin A = Doxorubicin (ADRIAMYCIN ) C = Cyclophosphamide ABOUT THIS MEDICATION What are these drugs used for? LUOTPAC is an intravenous (through the vein) drug treatment for Thymoma and Thymic Carcinoma. The goal of this treatment is to help control or shrink the cancer and some of the symptoms caused by it. This treatment is offered to people who have good kidney function and a good performance status. Performance status is a measure of how well a person is able to perform their usual daily activities. How do these drugs work? Cisplatin is an anticancer drug that works by preventing the synthesis of DNA, RNA and proteins that are needed for cancer cells to divide. Doxorubicin is an anticancer drug that works by interfering with the synthesis of DNA and RNA that are needed for cancer cells to divide. Cyclophosphamide is an anticancer drug that works by interfering with the synthesis of DNA, RNA, and proteins that are needed for cancer cells to divide. INTENDED BENEFITS This treatment is being given to destroy and/or limit the growth of cancer cells in your body. This treatment may improve your current symptoms, and delay or prevent new symptoms from starting. LUOTPAC TREATMENT SUMMARY How are these drugs given? Your treatment plan consists of up to 8 therapy cycles. Each cycle lasts 3 weeks (21 days). For each cycle, you will have the three medications given to you intravenously (through the vein) on Day 1. BC Cancer Agency Protocol Summary (Patient Version) LUOTPAC 1/8

- Doxorubicin is given first, and is given as an injection. - You will then be given extra fluids intravenously for one hour (60 minutes) before cisplatin. This is to help flush out your kidneys. - Cisplatin is given second, and is given intravenously over one hour (60 minutes). - Cyclophosphamide is given last, and is given intravenously over approximately one hour (20-60 minutes). What will happen when I get my drugs? A blood test is done within one month of starting treatment. A blood test is also done before Day 1 of each cycle. The dose and timing of your therapy may be changed based on your blood test results and/or other side effects. Your very first treatment will take longer than other treatments because a nurse will be reviewing the possible side effects of your therapy plan and will discuss with you how to manage them. It is a good idea to bring someone with you to your first therapy appointment. You will be given a prescription for anti-nausea medications (to be filled at your regular pharmacy). Please bring your anti-nausea medications with you for each treatment. Your nurse will tell you when to take the anti-nausea medication. You may also need to take your anti-nausea drugs at home after therapy. It is easier to prevent nausea than to treat it once it happens, so follow directions closely. LUOTPAC TREATMENT PROTOCOL Start Date: Cycle 1: Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Blood Test Doxorubicin, Cisplatin, Cyclophosphamide Chemo Chemo Day 8 Day 9 Day 10 Day 11 Day 12 Day 13 Day 14 Day 15 Day 16 Day 17 Day 18 Day 19 Day 20 Day 21 This 21-day cycle will repeat up to 7 more times. BC Cancer Agency Protocol Summary (Patient Version) LUOTPAC 2/8

CHEMOTHERAPY SIDE EFFECTS AND MANAGEMENT Are there any risks? Unexpected and unlikely side effects can occur with any drug treatment. The ones listed below are particularly important for you to be aware of. SERIOUS SIDE EFFECTS Your white blood cells will decrease after your treatment. They usually return to normal within 3 weeks. White blood cells protect your body by fighting bacteria (germs) that cause infection. When they are low, you are at greater risk of having an infection. Your platelets may decrease after your treatment. Platelets help to make your blood clot when you hurt yourself. You may bruise or bleed more easily than usual. Doxorubicin and cisplatin burn if they leak under the skin. How Common Is It? Very Common Common Rare MANAGEMENT To help prevent infection: Wash your hands often and always after using the bathroom. Take care of your skin and mouth by gently washing regularly. Avoid crowds and people who are sick. Call your doctor immediately at the first sign of an infection such as fever (over 100 F or 38 C by an oral thermometer), chills, cough or burning when you pass urine. To help prevent bleeding problems: Try not to bruise, cut or burn yourself. Clean your nose by blowing gently, do not pick your nose. Brush your teeth gently with a soft toothbrush as your gums may bleed more easily. Maintain good oral hygiene. Avoid taking ASA (eg: ASPIRIN ) or Ibuprofen (eg: ADVIL ), unless prescribed by your doctor. Tell your nurse or doctor immediately if you feel burning, stinging, or any other change while the drugs are being given. BC Cancer Agency Protocol Summary (Patient Version) LUOTPAC 3/8

SERIOUS SIDE EFFECTS Allergic reactions to cisplatin may rarely occur. Signs of an allergic reaction are dizziness, confusion and wheezing. This reaction may occur immediately or several hours after receiving cisplatin. This reaction can occur after the first dose of cisplatin or after many doses of cisplatin. How Common Is It? Rare MANAGEMENT Tell your nurse if this happens while you are receiving cisplatin or contact your oncologist immediately if this happens after you leave the clinic. OTHER SIDE EFFECTS Nausea and vomiting may occur after your treatment. It usually ends within 24 hours, but may last longer for some patients (i.e. delayed nausea and vomiting). How Common Is It? Very Common MANAGEMENT You will be given a prescription for anti-nausea drug(s) to take before your therapy treatment and/or at home. It is easier to prevent nausea than to treat it once it has happened, so follow directions closely. Drink plenty of liquids. Eat and drink often in small amounts. Try the ideas in Food Choices to Control Nausea. Your doctor may manage delayed nausea and vomiting differently. Be sure to let your doctor know if you experience this. BC Cancer Agency Protocol Summary (Patient Version) LUOTPAC 4/8

Hair loss is common and may begin within a few days or weeks of treatment. Your hair may thin or you may become totally bald. Your scalp may feel tender. You may lose hair on your face and body. Your hair will grow back once your treatments are over and sometimes between treatments. Colour and texture may change. Sore mouth may occur a few days after treatment. Mouth sores can occur on the tongue, the sides of the mouth or in the throat. Mouth sores or bleeding gums can lead to an infection. Very Common Use a gentle shampoo and soft brush. Care should be taken with use of hair spray, bleaches, dyes, and perms. Protect your scalp with a hat, scarf or wig in cold weather. Cover your head or apply sunblock on sunny days. Apply mineral oil to your scalp to reduce itching. If you lose your eyelashes and eyebrows, protect your eyes from dust and grit with a broad-rimmed hat and glasses. Common Brush your teeth gently after eating and at bedtime with a very soft toothbrush. If your gums bleed, use gauze instead of a brush. Use baking soda instead of toothpaste. Make a mouthwash with ½ teaspoon baking soda or salt in 1 cup warm water and rinse several times a day. Try soft, bland foods like puddings, milkshakes and cream soups. Avoid spicy, crunchy or acidic food, and very hot or cold foods. Call your doctor if you are having difficulty eating or drinking due to pain. Try the ideas in Help with Sore Mouth during Chemotherapy Diarrhea may occur. Common To help diarrhea: Drink plenty of liquids. Eat and drink often in small amounts. Avoid high fibre foods as outlined in Food Ideas to Help with Diarrhea. BC Cancer Agency Protocol Summary (Patient Version) LUOTPAC 5/8

Loss of appetite and weight loss are common and may persist after your treatments are over. Pain or tenderness may occur where the needle was placed in your vein. Nasal congestion may occur during administration of cyclophosphamide. You may experience runny eyes and nose, sinus congestion and sneezing during or immediately after the infusion. Your skin may darken in some areas such as your nails, soles or palms. Common Try ideas in High Energy High Protein Ideas and in Healthy Eating Using High Energy, High Protein Foods. Uncommon Apply cool compresses or soak in cool water for 15-20 minutes several times a day. Uncommon For persistent nasal congestion a decongestant such as pseudoephedrine (e.g., SUDAFED ), or a decongestant/antihistamine can be used to relieve symptoms. Uncommon This will slowly return to normal once you stop treatment. Headache may occur. Uncommon For minor pain, take acetaminophen (e.g., TYLENOL ). BC Cancer Agency Protocol Summary (Patient Version) LUOTPAC 6/8

INSTRUCTIONS FOR THE PATIENT What other drugs can interact with LUOTPAC? Other drugs such as some antibiotics given by vein (e.g., tobramycin, vancomycin), furosemide (LASIX ), phenytoin (DILANTIN ), pyridoxine, allopurinol, amiodarone, digoxin (LANOXIN ), hydrochlorothiazide, indomethacin (INDOCID ), warfarin (COUMADIN ) and cyclosporine (NEORAL or SANDIMMUNE ) may interact with LUOTPAC. Tell your doctor if you are taking these or other drugs as you may need extra blood tests, your dose may need to be changed or your treatment may need to be held for a few days. Check with your doctor or pharmacist before you start taking any new prescription or non-prescription drugs. Other important things to know: Heart failure: rarely, doxorubicin can have a serious effect on the heart, causing failure of the heart s pumping action, which results in shortness of breath, fatigue and leg swelling. Your treatment may be stopped or interrupted if there are concerns about your heart function. Tell your doctor if you have ever had an unusual or allergic reaction to daunorubicin, epirubicin, idamycin, mitomycin or mitoxantrone before treatment begins. Your doctor may tell you to drink plenty of liquids (e.g., 8-12 cups or 2000-3000mL) every day. You may also be told to empty your bladder (pass urine) frequently, every 2 hours while you are awake and at bedtime for at least 24 hours after your treatment. Your doctor may also tell you to get up in the night to empty your bladder. This helps prevent bladder and kidney problems. Your urine may be pink or reddish for 1-2 days after your treatment. This is expected as doxorubicin is red and is passed in your urine. The drinking of alcohol (in small amounts) does not appear to affect the safety or usefulness of this treatment. Sometimes, the nerve which allows you to hear can be affected by cisplatin. This could result in you experiencing tinnitus (ringing in the ears) or a change in your hearing. Report any of these problems to your doctor and/or nurse. Cisplatin can cause changes in kidney function, but this is not frequent with the doses used in this type of treatment. It is important that you are well-hydrated before and after treatment. This treatment may cause sterility in men and menopause in women. If you plan to have children, discuss this with your doctor before starting treatment. This treatment may damage sperm and may cause harm to the baby if used during pregnancy. It is best to use birth control while you are undergoing treatment. Tell your doctor right away if you or your partner becomes pregnant. Do not breast feed during treatment. Tell all doctors or dentists you see that you are being treated with cyclophosphamide, doxorubicin and cisplatin before you receive treatment of any form. BC Cancer Agency Protocol Summary (Patient Version) LUOTPAC 7/8

SEE YOUR DOCTOR OR GET EMERGENCY HELP IMMEDIATELY IF YOU HAVE: Signs of an infection such as fever (over 100 F or 38 C by an oral thermometer); chills; cough; pain or burning when you pass urine. Signs of bleeding problems such as black, tarry stools; blood in urine; pinpoint red spots on skin; extensive bruising. Signs of an allergic reaction (rare) soon after a treatment including dizziness, fast heartbeat, face swelling or breathing problems. Signs of heart problems such as fast or uneven heartbeat, chest pain, chest pressure, shortness of breath or difficulty breathing, swelling of ankles or fainting. Signs of a stroke such as sudden onset of: severe headache, eyesight changes, slurred speech, loss of coordination, weakness or numbness in arm or leg. Signs of a blood clot such as tenderness or hardness over a vein, calf swelling and tenderness, sudden onset of cough, chest pain or shortness of breath. Seizures or loss of consciousness. SEE YOUR DOCTOR AS SOON AS POSSIBLE (DURING OFFICE HOURS) IF YOU HAVE: Muscle weakness. Signs of bladder problems such as changes in urination, painful burning sensation, presence of blood or abdominal pain. Signs of anemia such as unusual tiredness or weakness. Signs of gout such as joint pain. Changes in eyesight. Signs of kidney problems such as lower back or side pain, swelling of feet. Uncontrolled nausea, vomiting, or diarrhea. CHECK WITH YOUR DOCTOR IF ANY OF THE FOLLOWING CONTINUE TO BOTHER YOU: Easy bruising or bleeding. Redness, swelling, pain or sores where the needle was placed. Redness, swelling, pain or sores on your lips, tongue, mouth or throat. Ringing in your ears or hearing problems. Sings of anemia such as unusual tiredness or weakness. Skin rash or itching. Numbness or tingling in feet or hands or painful leg cramps. For diabetics: uncontrolled blood sugars. Headache not controlled with acetaminophen. If you experience symptoms or changes in your body that have not been described above but worry you, or if any symptoms are severe, contact: at telephone number BC Cancer Agency Protocol Summary (Patient Version) LUOTPAC 8/8